[go: up one dir, main page]

DK608589D0 - Kemisk fremgangsmaade - Google Patents

Kemisk fremgangsmaade

Info

Publication number
DK608589D0
DK608589D0 DK608589A DK608589A DK608589D0 DK 608589 D0 DK608589 D0 DK 608589D0 DK 608589 A DK608589 A DK 608589A DK 608589 A DK608589 A DK 608589A DK 608589 D0 DK608589 D0 DK 608589D0
Authority
DK
Denmark
Prior art keywords
chemical procedure
procedure
chemical
Prior art date
Application number
DK608589A
Other languages
English (en)
Original Assignee
Holm Arne
Houen Gunnar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holm Arne, Houen Gunnar filed Critical Holm Arne
Priority to DK608589A priority Critical patent/DK608589D0/da
Publication of DK608589D0 publication Critical patent/DK608589D0/da
Priority to PCT/DK1990/000311 priority patent/WO1991008220A1/en
Priority to AU68929/91A priority patent/AU6892991A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
DK608589A 1989-12-01 1989-12-01 Kemisk fremgangsmaade DK608589D0 (da)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DK608589A DK608589D0 (da) 1989-12-01 1989-12-01 Kemisk fremgangsmaade
PCT/DK1990/000311 WO1991008220A1 (en) 1989-12-01 1990-11-30 A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines
AU68929/91A AU6892991A (en) 1989-12-01 1990-11-30 A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK608589A DK608589D0 (da) 1989-12-01 1989-12-01 Kemisk fremgangsmaade

Publications (1)

Publication Number Publication Date
DK608589D0 true DK608589D0 (da) 1989-12-01

Family

ID=8147293

Family Applications (1)

Application Number Title Priority Date Filing Date
DK608589A DK608589D0 (da) 1989-12-01 1989-12-01 Kemisk fremgangsmaade

Country Status (3)

Country Link
AU (1) AU6892991A (da)
DK (1) DK608589D0 (da)
WO (1) WO1991008220A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2745351B2 (ja) * 1991-02-14 1998-04-28 富士写真フイルム株式会社 ペプチド誘導体及びその用途
DE69226197T2 (de) * 1991-11-08 1999-02-11 Somatogen, Inc., Boulder Hämoglobine als arzneimittelabgabesystem
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5557033A (en) * 1992-09-22 1996-09-17 Regents Of The University Of Minnesota Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide
US5670347A (en) 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
AU2887195A (en) * 1994-06-24 1996-01-19 Akzo Nobel N.V. Kit for pretargeting and novel pretargeting conjugates
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
DE19636889A1 (de) * 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
WO1999024462A2 (en) * 1997-11-07 1999-05-20 Conjuchem, Inc. Novel conjugates of rgd-containing peptides and endogenous carriers
EP1167383B1 (en) * 1997-11-07 2003-03-26 Conjuchem, Inc. Novel conjugates of opioids and endogenous carriers
US6437092B1 (en) 1998-11-06 2002-08-20 Conjuchem, Inc. Conjugates of opioids and endogenous carriers
WO2001077137A1 (en) 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins
SI1180121T1 (en) 1999-05-17 2004-04-30 Conjuchem, Inc. Long lasting insulinotropic peptides
US6706892B1 (en) 1999-09-07 2004-03-16 Conjuchem, Inc. Pulmonary delivery for bioconjugation
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
WO2002062844A2 (en) 2001-02-02 2002-08-15 Conjuchem Inc. Long lasting growth hormone releasing factor derivatives
EP1360202B1 (en) 2001-02-16 2008-05-21 ConjuChem Biotechnologies Inc. Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
EP2277889B1 (en) 2001-12-21 2014-07-09 Human Genome Sciences, Inc. Fusion proteins of albumin and interferon beta
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
TW202019458A (zh) * 2018-06-27 2020-06-01 美商裘美娜治療公司 肝素相關多肽及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2047413C3 (de) * 1970-09-26 1980-05-29 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Verfahren zur Herstellung von Peptiden in homogener Phase
US4859765A (en) * 1983-10-17 1989-08-22 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4596674A (en) * 1984-09-11 1986-06-24 Merck & Co., Inc. Immunogenic HAV peptides
GB8610551D0 (en) * 1986-04-30 1986-06-04 Hoffmann La Roche Polypeptide & protein derivatives
FR2612519B1 (fr) * 1987-03-20 1989-12-15 Rhone Merieux Nouvelles fractions peptidiques inductrices d'anticorps protecteurs contre le virus de la leucemie bovine, procede pour l'obtention de telles fractions, leurs sequences codantes et vaccins realises a partir de ces fractions
DE3806198A1 (de) * 1988-02-04 1989-08-17 Boehringer Mannheim Gmbh Immunogen und seine verwendung zur gewinnung von antikoerpern gegen hba(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)c(pfeil abwaerts)

Also Published As

Publication number Publication date
AU6892991A (en) 1991-06-26
WO1991008220A1 (en) 1991-06-13

Similar Documents

Publication Publication Date Title
DE69033697D1 (de) Mykonematizide
DK608589D0 (da) Kemisk fremgangsmaade
FI901319A7 (fi) Parannettuja kemiallisia yhdisteitä
DE69028192D1 (de) Ablenkjoch
BR9000014A (pt) Classificaodr
DE69027258D1 (de) Phenacylpyridiniothiocephalosporine
FI900499A7 (fi) Kemiallinen menetelmä
FI910059A7 (fi) Kemialliset yhdisteet
BR8907374A (pt) Composto quimico
DD294367A5 (de) Farbbildroehre
BR9001818A (pt) Girotrom quase-otico
ATA149789A (de) Schienenrad
DK164309C (da) Mnemoteknisk hjaelpemiddel
DE59010414D1 (de) Fluorphenylpyridine
DD284561A5 (de) Chiptraeger
DK474289D0 (da) Kemiske forbindelser
MX9102047A (es) Procedimiento quimico
BR6900796U (pt) Eletro-lamina
BR8906438A (pt) Super-domino
SE8903429D0 (sv) Oljelaensa
SE8901810D0 (sv) Fjaederklaemma
BR6901431U (pt) Bate-pula
BR6901354U (pt) Mosquetao
ATA152989A (de) Skistock
BR6900607U (pt) Mini-cone

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment